Reporting suspected adverse events. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases43

Drug-Related Side Effects and Adverse Reactions Iatrogenic Disease Gastrointestinal Diseases Nausea Recurrence Postoperative Complications Headache Smallpox Vomiting Exanthema Disease Progression Neoplasms Hand-Foot Syndrome Neutropenia Pain Fatigue Arthritis, Rheumatoid Fever Drug Eruptions Drug Hypersensitivity Acute Disease Hemorrhage Asthenia HIV Infections Yellow Fever Akathisia, Drug-Induced Pericarditis Chronic Disease Diarrhea Thrombocytopenia Myocardial Infarction Neoplasm Metastasis Constipation Anemia Intussusception Nasopharyngitis Neoplasm Recurrence, Local Breast Neoplasms Intraoperative Complications Guillain-Barre Syndrome Skin Diseases, Bacterial Psychomotor Agitation Lung Neoplasms

Chemicals and Drugs86

Placebos Smallpox Vaccine Antibodies, Monoclonal, Humanized Antineoplastic Agents Drug Combinations Antibodies, Monoclonal Antirheumatic Agents Yellow Fever Vaccine Delayed-Action Preparations Vaccines Anti-Inflammatory Agents, Non-Steroidal Immunosuppressive Agents Triazoles Ethanolamines Pyrimidines Anticonvulsants Pyrroles Deoxycytidine Phenylurea Compounds Piperazines Artemisinins Anti-Bacterial Agents Niacinamide Benzenesulfonates Polyethylene Glycols Sulfonamides Methotrexate Taxoids Antibodies, Monoclonal, Murine-Derived Antiviral Agents Quinazolines Vaccines, Combined Gastrointestinal Agents Thalidomide Indoles Bronchodilator Agents Ointments Fluorouracil Isoxazoles Pyridines Anti-Infective Agents Antimalarials Sulfones Diclofenac Influenza Vaccines Fluorenes Angiogenesis Inhibitors Quinolines Piracetam Adrenal Cortex Hormones Sirolimus Recombinant Proteins Hypnotics and Sedatives Dermatologic Agents Interferon-alpha Anti-HIV Agents Protein Kinase Inhibitors Thiophenes Hypoglycemic Agents Immunologic Factors Bone Density Conservation Agents Benzimidazoles Antihypertensive Agents Gout Suppressants Organoplatinum Compounds Anticoagulants Antifungal Agents Glucocorticoids Albuterol Analgesics, Opioid Vaccines, Inactivated Antipsychotic Agents Anti-Inflammatory Agents Pregnadienediols Azithromycin Azathioprine Acetamides Anti-Ulcer Agents Benzamides Drugs, Investigational Viscosupplements Pyrazoles Anti-Asthmatic Agents Tacrolimus Vaginal Creams, Foams, and Jellies Ribavirin

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Adverse Drug Reaction Reporting Systems Treatment Outcome Double-Blind Method Drug Administration Schedule Drug Therapy, Combination Product Surveillance, Postmarketing Placebos Administration, Oral Prospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Retrospective Studies Pilot Projects Infusions, Intravenous Kaplan-Meier Estimate Pharmacovigilance Antineoplastic Combined Chemotherapy Protocols Risk Assessment Severity of Illness Index Risk Factors Cross-Over Studies Disease-Free Survival Area Under Curve Single-Blind Method Drug Substitution Delayed-Action Preparations Maximum Tolerated Dose Incidence Feasibility Studies Treatment Failure Drug Monitoring Cohort Studies Vaccination Clinical Trials, Phase III as Topic Medication Errors Injections, Subcutaneous Survival Analysis Clinical Trials as Topic Survival Rate Pain Measurement Hospitalization Injections, Intravenous Acupuncture Therapy Retreatment Equipment Failure Administration, Inhalation Injections, Intramuscular Endpoint Determination Conscious Sedation Research Design Remission Induction Mass Vaccination Combined Modality Therapy Medical Records Drug Labeling Prognosis Administration, Topical Chi-Square Distribution Neoplasm Staging Stents Phytotherapy Logistic Models Multicenter Studies as Topic Proportional Hazards Models Clinical Protocols Patient Selection Administration, Intravenous Clinical Trials, Phase II as Topic Questionnaires Administration, Cutaneous Hospital Records Equipment Safety Length of Stay Salvage Therapy Surgical Procedures, Operative Multivariate Analysis Registries Drug Approval Vaginal Creams, Foams, and Jellies Early Termination of Clinical Trials

Psychiatry and Psychology4

Scapegoating Pain Patient Compliance Psychomotor Agitation

Phenomena and Processes10

Dose-Response Relationship, Drug Time Factors Area Under Curve Maximum Tolerated Dose Pain Drug Interactions Chi-Square Distribution Therapeutic Equivalency Drug Tolerance Half-Life

Disciplines and Occupations4

Research Design Outcome Assessment (Health Care)Hospital Administration Postanesthesia Nursing

Anthropology, Education, Sociology and Social Phenomena5

United States Food and Drug Administration Malpractice Quality of Life Liability, Legal Drug Approval

Technology, Industry, Agriculture2

Polyethylene Glycols Drug Labeling

Humanities1

Quality of Life

Information Science11

Adverse Drug Reaction Reporting Systems Pharmacovigilance Incidence Survival Rate Medical Records Databases, Factual Data Mining Systems Analysis Questionnaires Hospital Records Registries

Named Groups4

Healthy Volunteers Infant, Newborn Nursing Staff, Hospital Patient Dropouts

Health Care70

Adverse Drug Reaction Reporting Systems Treatment Outcome Medical Errors Double-Blind Method Safety Prospective Studies Safety Management Risk Management United States Food and Drug Administration Randomized Controlled Trials as Topic Follow-Up Studies Patient Safety Retrospective Studies Pilot Projects Kaplan-Meier Estimate Pharmacovigilance Intention to Treat Analysis Risk Assessment Severity of Illness Index Risk Factors Cross-Over Studies Malpractice Disease-Free Survival Area Under Curve Single-Blind Method Drug Substitution Incidence Feasibility Studies Treatment Failure Medical Audit Cohort Studies Vaccination Clinical Trials, Phase III as Topic Medication Errors Survival Analysis Clinical Trials as Topic Survival Rate Cost-Benefit Analysis Hospitalization Patient Satisfaction Outcome Assessment (Health Care)Consumer Product Safety Mass Vaccination Medical Records Patient Compliance Quality Assurance, Health Care Hospital Administration Age Factors Hospitals, Teaching Chi-Square Distribution Logistic Models Immunization Programs Multicenter Studies as Topic Nursing Audit Proportional Hazards Models Clinical Protocols Patient Selection Academic Medical Centers Hospitals Clinical Trials, Phase II as Topic Questionnaires Hospital Records Liability, Legal Nursing Staff, Hospital Length of Stay Emergency Service, Hospital Multivariate Analysis Registries Postanesthesia Nursing Early Termination of Clinical Trials

Geographicals5

United States Japan Europe Canada Great Britain

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Adverse Drug Reaction Reporting Systems Treatment Outcome Medical Errors Double-Blind Method Drug-Related Side Effects and Adverse Reactions Drug Administration Schedule Drug Therapy, Combination Iatrogenic Disease Product Surveillance, Postmarketing Placebos Administration, Oral Safety Prospective Studies Safety Management Risk Management Dose-Response Relationship, Drug United States Food and Drug Administration Randomized Controlled Trials as Topic Follow-Up Studies Patient Safety Time Factors Retrospective Studies Smallpox Vaccine Antibodies, Monoclonal, Humanized Antineoplastic Agents Drug Combinations Pilot Projects Infusions, Intravenous Gastrointestinal Diseases Kaplan-Meier Estimate Nausea Pharmacovigilance Antibodies, Monoclonal Antineoplastic Combined Chemotherapy Protocols Antirheumatic Agents Intention to Treat Analysis Risk Assessment United States Severity of Illness Index Risk Factors Cross-Over Studies Malpractice Disease-Free Survival Area Under Curve Recurrence Single-Blind Method Yellow Fever Vaccine Postoperative Complications Drug Substitution Delayed-Action Preparations Vaccines Maximum Tolerated Dose Headache Smallpox Vomiting Incidence Anti-Inflammatory Agents, Non-Steroidal Feasibility Studies Exanthema Treatment Failure Immunosuppressive Agents Medical Audit Triazoles Drug Monitoring Cohort Studies Quality of Life Ethanolamines Vaccination Clinical Trials, Phase III as Topic Medication Errors Injections, Subcutaneous Survival Analysis Clinical Trials as Topic Survival Rate Disease Progression Neoplasms Hand-Foot Syndrome Cost-Benefit Analysis Pain Measurement Neutropenia Healthy Volunteers Scapegoating Pain Drug Interactions Pyrimidines Anticonvulsants Hospitalization Pyrroles Deoxycytidine Fatigue Phenylurea Compounds Injections, Intravenous Acupuncture Therapy Piperazines Artemisinins Anti-Bacterial Agents Niacinamide Benzenesulfonates Arthritis, Rheumatoid Polyethylene Glycols

No FAQ available that match "reporting suspected adverse events"